SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-013303
Filing Date
2018-05-14
Accepted
2018-05-14 06:45:24
Documents
3
Period of Report
2018-05-10
Items
Item 1.02: Termination of a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 2.05: Cost Associated with Exit or Disposal Activities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K life-8k_20180510.htm 8-K 36714
2 EX-99.1 life-ex991_6.htm EX-99.1 109675
3 GRAPHIC g201805132141443034739.jpg GRAPHIC 3474
  Complete submission text file 0001564590-18-013303.txt   152603
Mailing Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121
Business Address 3545 JOHN HOPKINS COURT, STE #250 SAN DIEGO CA 92121 858-731-8389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 18828621
SIC: 2836 Biological Products, (No Diagnostic Substances)